Healthy Skepticism Library item: 7164
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Pfizer Woe Expected To Spark Consolidation
New Ratings.com 2006 Dec 4
http://www.newratings.com/analyst_news/article_1436057.html
Abstract:
Pharmceutical sector will see a lot of M&A speculation Monday, as Pfizer (PFE) is seen as under pressure to strengthen its pipeline through takeovers after it stopped development of a key drug on safety issues, says an analyst. “Discussing potential takeover targets will be the focus today,” says a pharmaceutical analyst. “You can pick anybody, except Roche (RHHBY) which is protected, thanks to its shareholder structure.” At Roche, the founding family controls a majority of the voting capital and has persistently made it clear, that it’s unwilling to sell
